Elevation Oncology (ELEV) Enterprise Value
Price: $0.26
Market Cap: $15.40M
Avg Volume: 2.37M
Market Cap: $15.40M
Avg Volume: 2.37M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Elevation Oncology's latest quarterly financial reports:
- The enterprise value (EV) is 14.93M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 32.22M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $0.5626, with 59.12M shares outstanding.
- The company has 49.46M in cash and cash equivalents and 31.13M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$14.93M
Market Cap
$33.26M
Total Debt
$31.13M
Cash and Equivalents
$49.46M
Historical Enterprise Value
Elevation Oncology Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $14.93M | -18.31% | $0.5626 | 59.12M | $33.26M | $49.46M | $31.13M |
| September 30, 2024 | $18.28M | -86.97% | $0.5999 | 59.11M | $35.46M | $48.20M | $31.02M |
| June 30, 2024 | $140.26M | -20.56% | $2.86 | 59.02M | $168.79M | $59.45M | $30.92M |
| March 31, 2024 | $176.56M | 4724.97% | $4.99 | 47.37M | $236.39M | $90.63M | $30.81M |
| December 31, 2023 | $3.66M | 15.44% | $0.537 | 42.42M | $22.78M | $49.26M | $30.14M |
| September 30, 2023 | $3.17M | -109.15% | $0.6626 | 42.40M | $28.10M | $54.88M | $29.95M |
| June 30, 2023 | $-34.64M | -286.49% | $1.52 | 27.58M | $41.91M | $106.33M | $29.77M |
| March 31, 2023 | $18.57M | 228.44% | $1.9 | 23.62M | $44.88M | $55.90M | $29.60M |
| December 31, 2022 | $5.65M | 88.69% | $0.95 | 23.30M | $22.14M | $45.92M | $29.43M |
| September 30, 2022 | $3.00M | -114.06% | $1.13 | 23.29M | $26.32M | $52.59M | $29.27M |
| June 30, 2022 | $-21.32M | -487.85% | $1.4 | 23.26M | $32.56M | $53.88M | $- |
| March 31, 2022 | $5.50M | -107.50% | $2.52 | 23.22M | $58.50M | $53.01M | $- |
| December 31, 2021 | $-73.25M | -394.57% | $6.02 | 12.13M | $73.04M | $146.28M | $- |
| September 30, 2021 | $24.87M | -117.29% | $7.79 | 23.11M | $180.06M | $155.20M | $- |
| June 30, 2021 | $-143.82M | -175.23% | $13.57 | 1.05M | $14.20M | $158.02M | $- |
| March 31, 2021 | $191.17M | 74.14% | $11.44 | 22.82M | $261.09M | $69.91M | $- |
| December 31, 2020 | $109.78M | -41.97% | $11.44 | 16.54M | $189.18M | $79.40M | $- |
| September 30, 2020 | $189.18M | 0.00% | $11.44 | 16.54M | $189.18M | $- | $- |
| June 30, 2020 | $189.18M | -0.91% | $11.44 | 16.54M | $189.18M | $- | $- |
| March 31, 2020 | $190.92M | - | $11.44 | 16.54M | $189.18M | $-1.74M | $- |
Related Metrics
Explore detailed financial metrics and analysis for ELEV.